Issue 1/2016
Content (8 Articles)
Management of Cardiovascular Risk in Patients with Chronic Inflammatory Diseases: Current Evidence and Future Perspectives
Jesper Lindhardsen, Søren Lund Kristensen, Ole Ahlehoff
Medication Adherence Following Acute Coronary Syndrome: Does One Size Fit All?
Daniel D. L. Bernal, Luke R. E. Bereznicki, Leanne Chalmers, Ronald L. Castelino, Angus Thompson, Patricia M. Davidson, Gregory M. Peterson
Potential New Agents for the Management of Hyperkalemia
David K. Packham, Mikhail Kosiborod
Outcomes After Cardioversion in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral Anticoagulants (NOACs): Insights from a Meta-Analysis
Parijat Sen, Amartya Kundu, Partha Sardar, Saurav Chatterjee, Ramez Nairooz, Hossam Amin, Wilbert S. Aronow
Intravenous Clopidogrel (MDCO-157) Compared with Oral Clopidogrel: The Randomized Cross-Over AMPHORE Study
Jean-Philippe Collet, Christian Funck-Brentano, Jayne Prats, Joe-Elie Salem, Jean-Sébastien Hulot, Edith Guilloux, Ming-yi Hu, Kan He, Johanne Silvain, Vanessa Gallois, Delphine Brugier, Ghalia Anzaha, Sophie Galier, Nathalie Nicolas, Gilles Montalescot
Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial
Stephen J. Nicholls, Rishi Puri, Kathy Wolski, Christie M. Ballantyne, Philip J. Barter, H. Bryan Brewer, John J. P. Kastelein, Bo Hu, Kiyoko Uno, Yu Kataoka, Jean-Paul R. Herrman, Bela Merkely, Marilyn Borgman, Steven E. Nissen
Annual Congress of the European Society of Cardiology: August 29–September 2, 2015; London, UK
Amitabh Prakash